Cargando…
Virus-Based Biological Systems as Next-Generation Carriers for the Therapy of Central Nervous System Diseases
Central nervous system (CNS) diseases are currently a major challenge in medicine. One reason is the presence of the blood–brain barrier, which is a significant limitation for currently used medicinal substances that are characterized by a high molecular weight and a short half-life. Despite the app...
Autores principales: | Nowak, Ilona, Madej, Marcel, Secemska, Julia, Sarna, Robert, Strzalka-Mrozik, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384784/ https://www.ncbi.nlm.nih.gov/pubmed/37514117 http://dx.doi.org/10.3390/pharmaceutics15071931 |
Ejemplares similares
-
Molecular Mechanisms of the Antitumor Effects of Mesalazine and Its Preventive Potential in Colorectal Cancer
por: Słoka, Joanna, et al.
Publicado: (2023) -
Metagenomic Next-Generation Sequencing in Central Nervous System Angiostrongyliasis
por: Liao, Qiong, et al.
Publicado: (2022) -
Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid
por: Pentsova, Elena I., et al.
Publicado: (2016) -
Central Nervous System Infection Diagnosis by Next-Generation Sequencing: A Glimpse Into the Future?
por: Mai, Nguyen Thi Hoang, et al.
Publicado: (2017) -
Next generation sequencing for diagnosis of central nervous system aspergillosis in liver transplant recipients
por: Chen, Fang, et al.
Publicado: (2021)